These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Altered Interleukin-10 Signaling in Skeletal Muscle Regulates Obesity-Mediated Inflammation and Insulin Resistance. Dagdeviren S; Jung DY; Lee E; Friedline RH; Noh HL; Kim JH; Patel PR; Tsitsilianos N; Tsitsilianos AV; Tran DA; Tsougranis GH; Kearns CC; Uong CP; Kwon JY; Muller W; Lee KW; Kim JK Mol Cell Biol; 2016 Dec; 36(23):2956-2966. PubMed ID: 27644327 [TBL] [Abstract][Full Text] [Related]
4. SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice. Xu L; Nagata N; Nagashimada M; Zhuge F; Ni Y; Chen G; Mayoux E; Kaneko S; Ota T EBioMedicine; 2017 Jun; 20():137-149. PubMed ID: 28579299 [TBL] [Abstract][Full Text] [Related]
5. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties. Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229 [TBL] [Abstract][Full Text] [Related]
7. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model. Trajcevski KE; O'Neill HM; Wang DC; Thomas MM; Al-Sajee D; Steinberg GR; Ceddia RB; Hawke TJ PLoS One; 2013; 8(8):e71747. PubMed ID: 23951235 [TBL] [Abstract][Full Text] [Related]
8. High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice. Jorquera G; Meneses-Valdés R; Rosales-Soto G; Valladares-Ide D; Campos C; Silva-Monasterio M; Llanos P; Cruz G; Jaimovich E; Casas M Diabetologia; 2021 Jun; 64(6):1389-1401. PubMed ID: 33710396 [TBL] [Abstract][Full Text] [Related]
9. GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob/ob and high fat-fed mice. Ait-Omar A; Monteiro-Sepulveda M; Poitou C; Le Gall M; Cotillard A; Gilet J; Garbin K; Houllier A; Château D; Lacombe A; Veyrie N; Hugol D; Tordjman J; Magnan C; Serradas P; Clément K; Leturque A; Brot-Laroche E Diabetes; 2011 Oct; 60(10):2598-607. PubMed ID: 21852673 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Miller AM; Asquith DL; Hueber AJ; Anderson LA; Holmes WM; McKenzie AN; Xu D; Sattar N; McInnes IB; Liew FY Circ Res; 2010 Sep; 107(5):650-8. PubMed ID: 20634488 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model. Martins LMS; Perez MM; Pereira CA; Costa FRC; Dias MS; Tostes RC; Ramos SG; de Zoete MR; Ryffel B; Silva JS; Carlos D Immunology; 2018 May; 154(4):624-36. PubMed ID: 29722014 [TBL] [Abstract][Full Text] [Related]
12. NOD2 Deficiency Promotes Intestinal CD4+ T Lymphocyte Imbalance, Metainflammation, and Aggravates Type 2 Diabetes in Murine Model. Carlos D; Pérez MM; Leite JA; Rocha FA; Martins LMS; Pereira CA; Fraga-Silva TFC; Pucci TA; Ramos SG; Câmara NOS; Bonato VLD; Tostes RC; Silva JS Front Immunol; 2020; 11():1265. PubMed ID: 32774333 [TBL] [Abstract][Full Text] [Related]
13. Long-term exposure to a high-fat diet results in the development of glucose intolerance and insulin resistance in interleukin-1 receptor I-deficient mice. McGillicuddy FC; Reynolds CM; Finucane O; Coleman E; Harford KA; Grant C; Sergi D; Williams LM; Mills KH; Roche HM Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E834-44. PubMed ID: 23921145 [TBL] [Abstract][Full Text] [Related]
14. p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans. Ciciliot S; Albiero M; Menegazzo L; Poncina N; Scattolini V; Danesi A; Pagnin E; Marabita M; Blaauw B; Giorgio M; Trinei M; Foletto M; Prevedello L; Nitti D; Avogaro A; Fadini GP Diabetologia; 2015 Oct; 58(10):2352-60. PubMed ID: 26122877 [TBL] [Abstract][Full Text] [Related]
15. Gut-Specific Delivery of T-Helper 17 Cells Reduces Obesity and Insulin Resistance in Mice. Hong CP; Park A; Yang BG; Yun CH; Kwak MJ; Lee GW; Kim JH; Jang MS; Lee EJ; Jeun EJ; You G; Kim KS; Choi Y; Park JH; Hwang D; Im SH; Kim JF; Kim YK; Seoh JY; Surh CD; Kim YM; Jang MH Gastroenterology; 2017 Jun; 152(8):1998-2010. PubMed ID: 28246016 [TBL] [Abstract][Full Text] [Related]
16. Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metformin. Mahlangu TJ; Dludla PV; Mxinwa V; Mkandla Z; Tiano L; Louw J; Mutize T; Nyambuya TM; Nkambule BB Cytokine; 2020 Apr; 128():154999. PubMed ID: 32014718 [TBL] [Abstract][Full Text] [Related]
17. Resveratrol ameliorates high-fat diet-induced insulin resistance and fatty acid oxidation via ATM-AMPK axis in skeletal muscle. Zhang YJ; Zhao H; Dong L; Zhen YF; Xing HY; Ma HJ; Song GY Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9117-9125. PubMed ID: 31696503 [TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice. Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959 [TBL] [Abstract][Full Text] [Related]
19. MiR-495 regulates macrophage M1/M2 polarization and insulin resistance in high-fat diet-fed mice via targeting FTO. Hu F; Tong J; Deng B; Zheng J; Lu C Pflugers Arch; 2019 Dec; 471(11-12):1529-1537. PubMed ID: 31709454 [TBL] [Abstract][Full Text] [Related]
20. Adipocyte-specific deletion of IL-6 does not attenuate obesity-induced weight gain or glucose intolerance in mice. Whitham M; Pal M; Petzold T; Hjorth M; Egan CL; Brunner JS; Estevez E; Iliades P; Zivanovic B; Reibe S; Hughes WE; Findeisen M; Hidalgo J; Febbraio MA Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E597-E604. PubMed ID: 31386565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]